Refractory hematuria post actinic cystitis. Role of potassium alumen as treatment - Case Report

Main Article Content

João Ernesto Aldred Pinto Filho*
Pedro Henrique Ejje Kailly
Ruston da Matta Louback Filho
Juan Miguel Renteria
Antonio Claudio
Ahouagi Cunha

Abstract

Actinic cystitis hematuria is a frequent complication after pelvic radiotherapy, present in approximately 5% of patients exposed to this therapy. The management of these cases seems to be a challenge for today’s urologists. In this article, we present the case of a 73- year-old man diagnosed with actinic cystitis after pelvic radiotherapy and admitted to our service with a clinical picture of refractory macroscopic hematuria. During admission, the patient underwent multiple procedures and blood transfusions, without success in controlling hematuria. After a review of the literature, we chose to use Potassium Alum in the patient’s treatment. Under general anesthesia, we performed a cystoscopy with the evacuation of clots and subsequently infused a 1% solution of potassium alum into the bladder at a rate of 200 ml/h for 25 hours. Less than 24 hours after Alum infusion, there were no more clinical signs of hematuria, which remained until hospital discharge. After 6 months of treatment, the patient did not present another episode of hematuria.

Downloads

Download data is not yet available.

Article Details

Pinto Filho, J. E. A., Ejje Kailly, P. H., Louback Filho, R. da M., Renteria, J. M., Claudio, A., & Cunha, A. (2022). Refractory hematuria post actinic cystitis. Role of potassium alumen as treatment - Case Report. Global Journal of Medical and Clinical Case Reports, 9(2), 029–031. https://doi.org/10.17352/2455-5282.000153
Case Reports

Copyright (c) 2022 Aldred Pinto Filho JE, et al.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Rastinehad AR, Kavoussi LR, Noble MJ. Hemorrhagic cystitis. AUA Update Series. 2007.

Smit SG, Heyns CF. Management of radiation cystitis. Nat Rev Urol. 2010 Apr;7(4):206-14. doi: 10.1038/nrurol.2010.23. Epub 2010 Mar 9. PMID: 20212517.

Shepherd JD, Pringle LE, Barnett MJ, Klingemann HG, Reece DE, Phillips GL. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991 Nov;9(11):2016-20. doi: 10.1200/JCO.1991.9.11.2016. PMID: 1941060.

O'Reilly KJ, Hampson NB, Corman JM. Hyperbaric oxygen in urology. AUA Update Series. 2002.

Del Pizzo JJ, Chew BH, Jacobs SC, Sklar GN. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen: long-term followup. J Urol. 1998 Sep;160(3 Pt 1):731-3. doi: 10.1097/00005392-199809010-00026. PMID: 9720533.

Choong SK, Walkden M, Kirby R. The management of intractable haematuria. BJU Int. 2000 Dec;86(9):951-9. doi: 10.1046/j.1464-410x.2000.00900.x. PMID: 11119085.

Westerman ME, Boorjian SA, Linder BJ. Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: A contemporary evaluation. Int Braz J Urol. 2016 Nov-Dec;42(6):1144-1149. doi: 10.1590/S1677-5538.IBJU.2015.0588. PMID: 27509371; PMCID: PMC5117970.